Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine
Phase 3
Recruiting
- Conditions
- Allergic Rhinitis
- Interventions
- Drug: Desloratadine / Betamethasone in fixed dose
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 70
- Registration Number
- NCT06916884
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis
Phase 3
Recruiting
- Conditions
- Gout ArthritisGout Attack
- Interventions
- Drug: Etoricoxib + Betamethasone fixed dose
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 72
- Registration Number
- NCT06863701
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm
Phase 3
Recruiting
- Conditions
- Acute Low-back PainMuscle Spasm; Back Pain
- Interventions
- Drug: Etoricoxib + Tizanidine fixed dose
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 136
- Registration Number
- NCT06863662
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation
Phase 3
Recruiting
- Conditions
- Joint PainKnee OsteoarthritisHip Osteoarthritis
- Interventions
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 231
- Registration Number
- NCT06863636
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine
Phase 3
Recruiting
- Conditions
- Common Cold
- Interventions
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 177
- Registration Number
- NCT06531707
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back Pain
Phase 3
Completed
- Conditions
- Acute Low-back Pain
- Interventions
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 190
- Registration Number
- NCT06517823
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain
Phase 3
Completed
- Conditions
- Chronic Low-back Pain
- Interventions
- Drug: Celecoxib+Pregabalin+Vitamin B fixed dose
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 192
- Registration Number
- NCT06516094
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2022-09-08
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 42
- Registration Number
- NCT05533073
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen Oral Suspension
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 42
- Registration Number
- NCT05428293
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Pharmacokinetic Interaction Between Ibuprofen and Acetaminophen, Tablets Administered Individually or in Combination
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 42
- Registration Number
- NCT05428306
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
© Copyright 2025. All Rights Reserved by MedPath